EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BioTelemetry's enterprise value is $2,543.2 Mil.
BioTelemetry's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $438.8 Mil. Therefore, BioTelemetry's EV-to-Revenue for today is 5.80.
The historical rank and industry rank for BioTelemetry's EV-to-Revenue or its related term are showing as below:
BEAT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.57 Med: 4.58 Max: 7.12
Current: 5.8
During the past 13 years, the highest EV-to-Revenue of BioTelemetry was 7.12. The lowest was 3.57. And the median was 4.58.
As of today (2024-04-26), BioTelemetry's stock price is $71.96.
BioTelemetry's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $12.00. Therefore, BioTelemetry's PS Ratio for today is 6.00.
BioTelemetry EV-to-Revenue Historical Data
The historical data trend for BioTelemetry's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioTelemetry's EV-to-Revenue
For the Diagnostics & Research subindustry, BioTelemetry's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioTelemetry's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BioTelemetry's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where BioTelemetry's EV-to-Revenue falls into.
BioTelemetry's current Enterprise Value is $2,543.2 Mil.
BioTelemetry's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $438.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioTelemetry's share price for today is $71.96.
BioTelemetry's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioTelemetry EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of BioTelemetry's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BEAT has been successfully added to your 